A Consultation-Led Approach to Weight Management
Medical weight management refers to a structured, clinician-guided approach to weight-related health goals that may include a review of health history, lifestyle factors, and a discussion of medication options when appropriate. This page focuses on two medication classes that come up often in weight management conversations: semaglutide and tirzepatide.
Both are prescription medications belonging to categories sometimes described as GLP-1 receptor agonists and, in the case of tirzepatide, a dual GLP-1/GIP receptor agonist. These mechanisms relate to how the body regulates appetite and blood sugar, but whether either medication is relevant for a specific person depends on individual health history, goals, and an evaluation.
Use this page to understand the topic and prepare questions for a consultation about your goals and established options. It does not replace an individual consultation, and it does not promise that either medication is available, appropriate, or effective for any particular reader.
What an Evaluation for Weight Management May Consider
A weight management evaluation is generally focused on understanding the full picture of a person's health rather than jumping straight to a medication decision. Questions that may come up include current health conditions, prior weight management attempts, relevant family history, and any medications already being taken.
Laboratory testing may be requested when clinically relevant, though not every reader will need the same tests. Whether semaglutide, tirzepatide, or another approach might be worth discussing is something a clinician determines during individual review — this page cannot make that determination in advance.
If you are already using a weight management medication and are looking for a different provider or clearer follow-up, that context is useful information to raise during a consultation request rather than something to resolve on this page.
How Semaglutide and Tirzepatide Are Often Compared
Semaglutide and tirzepatide are frequently discussed side by side because they belong to related but distinct medication classes. Semaglutide acts on GLP-1 receptors, which are involved in appetite regulation and blood sugar control. Tirzepatide acts on both GLP-1 and GIP receptor pathways, which is why it is sometimes described as a dual-agonist medication.
These mechanism differences are a useful starting point for questions, not a basis for predicting how either medication might work for a specific individual. Neither medication is presented here as certain to produce a particular result, and this page does not state that either is currently available without individual review.
After a consultation request, the typical next step is a follow-up conversation with the care team, using the contact information provided, to discuss what an evaluation might look like and answer general questions. Use a consultation to discuss your questions and established options; the team can clarify what may apply to your situation.
What Happens After You Reach Out
Requesting a consultation starts a conversation, not a purchase. The team follows up using the contact details you provide to answer questions and explain what next steps may look like based on your situation. Submitting the form does not create a fixed promise of eligibility or a specific treatment outcome.
Frequently Asked Questions
Below are answers to common questions readers ask about medical weight management, semaglutide, and tirzepatide before requesting a consultation.
Ready to Discuss Your Situation?
If you have questions about medical weight management, semaglutide, or tirzepatide, request a consultation to speak with the care team about your situation and possible next steps. Contact Us to get started.
FAQs
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP receptor pathways, which is why it is often described as a dual-agonist medication. Both relate to appetite and blood sugar regulation, but whether either is relevant for you depends on individual review.
Do I need blood work before starting a weight management conversation?
Laboratory testing may be requested when clinically relevant, but not every reader needs the same tests. This is determined during an individual evaluation rather than in advance.
Is telehealth available for medical weight management consultations?
Telehealth availability depends on verified service details for the service areas we support. The most reliable way to find out is to request a consultation and ask directly.
I'm already taking a weight management medication. Can I still reach out?
Yes. If you're currently using a related medication and are looking for another provider or clearer follow-up, that's useful context to share when you request a consultation.
What happens after I submit a consultation request?
The care team follows up using the contact information you provide to discuss your questions and explain what an evaluation process may involve based on your situation.
Will semaglutide or tirzepatide definitely work for me?
No medication discussed on this page is presented as certain to produce a specific result. Outcomes vary by individual, and appropriateness is determined through clinician review, not through this page.